Modus Therapeutics Holding AB (publ) (STO:MODTX)

Market Cap	50.96M +4.3%
Revenue (ttm)	n/a
Net Income	-19.01M
EPS	-0.23
Shares Out	121.63M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,185,302
Open	0.4610
Previous Close	0.4640
Day's Range	0.4000 - 0.4610
52-Week Range	0.2080 - 5.0000
Beta	0.38
Analysts	n/a
Price Target	0.85 (+102.86%)
Earnings Date	May 26, 2026

About STO:MODTX

Modus Therapeutics Holding AB (publ), a biotechnology company, develops a treatment for sepsis and septic shock in Sweden. It develops Sevuparin, a lipopolysaccharide in Phase IIa trial to treat patients with sepsis, septic shock, anemia associated with chronic kidney disease, endotoxemia, severe malaria, and other diseases involving severe systemic inflammation. Modus Therapeutics Holding AB (publ) was founded in 2011 and is headquartered in Stockholm, Sweden.

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2011
• Employees: 2
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: MODTX